Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome
详细信息 查看全文
- 作者：Chun-mei Zhang (7) (8) (9)
Yue Zhao (7) (8) (9)
Rong Li (7) (8) (9)
Yang Yu (7) (8)
Li-ying Yan (7) (8)
Li Li (8) (9)
Na-na Liu (7) (9)
Ping Liu (7) (8)
Jie Qiao (7) (8) (9) - 关键词：PCOS ; Amino acid ; Obesity ; Follicular fluid
- 刊名：BMC Pregnancy and Childbirth
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：14
- 期：1
- 全文大小：181 KB
- 作者单位：Chun-mei Zhang (7) (8) (9)
Yue Zhao (7) (8) (9)
Rong Li (7) (8) (9)
Yang Yu (7) (8)
Li-ying Yan (7) (8)
Li Li (8) (9)
Na-na Liu (7) (9)
Ping Liu (7) (8)
Jie Qiao (7) (8) (9)
7. Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University Third Hospital, No. 49 Huayuan North Road, Beijing, Haidian District, 100191, People’s Republic of China
8. Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing, China
9. Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China - ISSN：1471-2393
文摘
Background Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder frequently accompanied by obesity and by insulin resistance, and patients with this syndrome suffer from infertility and poor pregnancy outcome. Disturbances in plasma amino acid (AA) metabolism have been implicated in women with PCOS. However, direct evidence on follicular AA metabolic profiles in PCOS patients and their relationship with pregnancy outcome is sparse. Methods We conducted a prospective study in 63 PCOS patients and 48 controls in the Division of Reproductive Center, Peking University Third Hospital. Follicular AA levels were measured by the liquid chromatography-tandem mass spectrometric method, and the results were analyzed based on different grouping criteria. Results The levels of aromatic amino acid (AAA) increased in PCOS patients independent of obesity (P-lt;-.05), whereas the levels of branched-chain amino acid (BCAA), glutamic acid, phenylalanine, alanine, and arginine increased with body mass index irrespective of the PCOS status (all P-lt;-.05). In addition, compared with non insulin resistant-PCOS patients and controls, insulin resistant-PCOS group had higher levels of leucine, valine and glutamic acid (all P-lt;-.05). In PCOS group, aspartic acid and serine levels were elevated in pregnant patients compared with the non-pregnant subjects (both P-lt;-.05). Moreover, the levels of BCAA and valine were higher in the non-pregnant group than in the pregnant group (both P-lt;-.05). The pregnancy rate (45.00%) of subjects with elevated BCAA level was significantly lower than that (66.67%) in control subjects (P--.036) at a BCAA cutoff value of 239.10?μM, while the abortion rate was much higher (33.33% versus 2.78%, P--.004). Conclusions Both PCOS and obesity were accompanied by follicular AA metabolic disturbances, with obesity exerting a more pronounced effect on AA metabolic profiles. The disruptions in specific AAs in the follicular fluid might account for the inferior pregnancy outcome in obese patients and increased risk of abortion in PCOS patients.